equol has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sareddy, GR; Vadlamudi, RK | 1 |
| Lampe, JW | 1 |
| Magee, PJ | 1 |
| Amiano, P; Ardanaz, E; Benetou, V; Boeing, H; Bueno-de-Mesquita, HB; Cassidy, A; Clavel-Chapelon, F; de Magistris, MS; Dilis, V; Drake, I; Fagherazzi, G; Förster, J; González, CA; Halkjær, J; Hjartåker, A; Huerta, JM; Johansson, G; Johansson, I; Kaas, R; Knaze, V; Kuhnle, GG; Luján-Barroso, L; Masala, G; Molina, E; Mouw, T; Mulligan, AA; Overvad, K; Peeters, PH; Perquier, F; Powell, N; Quirós, JR; Ricceri, F; Romaguera, D; Romieu, I; Ros, M; Sieri, S; Skie, G; Slimani, N; Sonestedt, E; Teucher, B; Tjønneland, A; Touillaud, M; Travis, RC; Trichopoulou, A; Tumino, R; Wark, PA; Zamora-Ros, R | 1 |
| Adlercreutz, H; Al-Maharik, N; Bagli, E; Bellou, S; Fotsis, T; Karali, E; Morbidelli, L; Murphy, C; Ziche, M | 1 |
| Bode, AM; Cho, YY; Dong, Z; Heo, YS; Kang, NJ; Lee, HJ; Lee, KW; Rogozin, EA | 1 |
| Griffiths, K; Morton, MS; Wahlqvist, ML; Wilcox, G | 1 |
| Kinjo, J | 1 |
3 review(s) available for equol and Neoplasms
| Article | Year |
|---|---|
Cancer therapy using natural ligands that target estrogen receptor beta.
Topics: Antineoplastic Agents, Phytogenic; Equol; Estrogen Receptor beta; Flavanones; Genistein; Glycine max; Glycyrrhiza; Humans; Ligands; Neoplasms; Phytotherapy; Plant Extracts | 2015 |
Emerging research on equol and cancer.
Topics: Animals; Biomarkers, Tumor; Equol; Female; Humans; Isoflavones; Male; Neoplasms | 2010 |
[Phytoestrogens].
Topics: Bacteria; Chromans; Digestive System; Equol; Estrogens, Non-Steroidal; Female; Gene Expression; Genistein; Humans; Isoflavones; Myocardial Ischemia; Neoplasms; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Receptors, Estrogen | 2000 |
5 other study(ies) available for equol and Neoplasms
| Article | Year |
|---|---|
Is equol production beneficial to health?
Topics: Antioxidants; Bone Diseases; Cardiovascular Diseases; Dihydrotestosterone; Equol; Glycine max; Hot Flashes; Humans; Intestinal Mucosa; Intestines; Isoflavones; Neoplasms; Phenotype; Phytoestrogens; Phytotherapy; Plant Extracts; Receptors, Estrogen; Risk Factors | 2011 |
Dietary intakes and food sources of phytoestrogens in the European Prospective Investigation into Cancer and Nutrition (EPIC) 24-hour dietary recall cohort.
Topics: Adult; Aged; Beverages; Body Mass Index; Cardiovascular Diseases; Coumarins; Diet; Edible Grain; Energy Intake; Equol; Europe; Female; Fruit; Glycine max; Humans; Isoflavones; Life Style; Lignans; Male; Middle Aged; Neoplasms; Nutritional Status; Phytoestrogens; Prospective Studies; Vegetables | 2012 |
The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.
Topics: Angiogenesis Inhibitors; Animals; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Equol; Female; Human Umbilical Vein Endothelial Cells; Humans; Isoflavones; MAP Kinase Signaling System; Mice; Mice, Nude; Mitosis; Neoplasms; Neovascularization, Pathologic; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.
Topics: Animals; Binding Sites; Cell Line; Epidermal Growth Factor; Equol; Extracellular Signal-Regulated MAP Kinases; Glycine max; Isoflavones; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; Models, Molecular; Molecular Structure; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-fos; ras Proteins; Replication Protein C; Ribosomal Protein S6 Kinases, 90-kDa; Tetradecanoylphorbol Acetate | 2007 |
Determination of lignans and isoflavonoids in human female plasma following dietary supplementation.
Topics: 4-Butyrolactone; Australia; Chromans; Diet; Equol; Estrogens; Female; Food, Fortified; Gas Chromatography-Mass Spectrometry; Genistein; Glycine max; Humans; Isoflavones; Lignans; Linseed Oil; Middle Aged; Monoamine Oxidase Inhibitors; Neoplasms; Plants, Edible; Postmenopause | 1994 |